Clearwater has advised Technolution, a Danish consultancy and development company in the pharma and MedTech markets, on its sale to MGS, a global medical device contract manufacturer.
Technolution is a fast-growing consultancy and development company in the pharma and MedTech markets, based in Hørsholm, north of Copenhagen, Denmark. The company is a market leader in its field and currently employs over 75 professionals across multiple disciplines, and to date, has handled more than 240 projects for start-ups, over the past 20 years. During that time, Technolution has gained a reputation as an expert in transforming ideas into innovative, healthcare solutions as well as fostering a culture of trust, integrity, and professionalism.
MGS is a global medical device contract manufacturer for the healthcare and pharma markets. Headquartered in Germantown, Wisconsin, in the US, MGS operates from 16 locations around the world. The company is acknowledged as a specialist in precision plastics, offering vertically integrated total solutions from a single source, providing exceptional value to its global clients.
This partnership establishes a unique position in the industry’s value chain, providing a seamless, one-stop-shop solution from initial design to final product delivery. By combining forces, Technolution and MGS will mitigate project risks for their clients, creating an approach that streamlines the supply chain and accelerates time-to-market.
